Talkspace (TALK) Competitors $2.64 -0.11 (-4.00%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.68 +0.04 (+1.36%) As of 07/11/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TALK vs. GRAL, NHC, TDOC, AHCO, VRDN, CDNA, PNTG, AVAH, AGL, and LFMDShould you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include GRAIL (GRAL), National HealthCare (NHC), Teladoc Health (TDOC), AdaptHealth (AHCO), Viridian Therapeutics (VRDN), CareDx (CDNA), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Agilon Health (AGL), and LifeMD (LFMD). These companies are all part of the "healthcare" industry. Talkspace vs. Its Competitors GRAIL National HealthCare Teladoc Health AdaptHealth Viridian Therapeutics CareDx The Pennant Group Aveanna Healthcare Agilon Health LifeMD Talkspace (NASDAQ:TALK) and GRAIL (NASDAQ:GRAL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk. Do institutionals & insiders believe in TALK or GRAL? 57.4% of Talkspace shares are held by institutional investors. 23.5% of Talkspace shares are held by insiders. Comparatively, 1.9% of GRAIL shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has stronger earnings and valuation, TALK or GRAL? Talkspace has higher revenue and earnings than GRAIL. GRAIL is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalkspace$187.59M2.35$1.15M$0.02132.00GRAIL$125.60M11.66-$2.03B-$60.99-0.67 Is TALK or GRAL more profitable? Talkspace has a net margin of 1.51% compared to GRAIL's net margin of -1,464.53%. Talkspace's return on equity of 2.54% beat GRAIL's return on equity.Company Net Margins Return on Equity Return on Assets Talkspace1.51% 2.54% 2.15% GRAIL -1,464.53%-17.99%-15.02% Does the media refer more to TALK or GRAL? In the previous week, Talkspace and Talkspace both had 3 articles in the media. Talkspace's average media sentiment score of 1.70 beat GRAIL's score of 1.24 indicating that Talkspace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talkspace 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive GRAIL 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend TALK or GRAL? Talkspace presently has a consensus price target of $4.50, suggesting a potential upside of 70.45%. GRAIL has a consensus price target of $31.50, suggesting a potential downside of 22.66%. Given Talkspace's stronger consensus rating and higher possible upside, equities research analysts clearly believe Talkspace is more favorable than GRAIL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00GRAIL 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 SummaryTalkspace beats GRAIL on 14 of the 15 factors compared between the two stocks. Get Talkspace News Delivered to You Automatically Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TALK vs. The Competition Export to ExcelMetricTalkspaceMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$460.12M$2.00B$5.61B$9.11BDividend YieldN/AN/A5.24%4.01%P/E Ratio132.0734.5627.9620.25Price / Sales2.3515.80430.8999.65Price / Cash231.4656.3037.4658.16Price / Book3.838.368.045.49Net Income$1.15M-$62.39M$3.18B$250.27M7 Day Performance-4.35%5.08%3.68%4.80%1 Month Performance-12.00%8.13%4.10%7.68%1 Year Performance23.36%5.64%29.59%16.36% Talkspace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TALKTalkspace3.9223 of 5 stars$2.64-4.0%$4.50+70.5%+24.5%$460.12M$187.59M132.07500News CoveragePositive NewsGRALGRAIL0.6669 of 5 stars$51.42+6.3%$31.50-38.7%+179.5%$1.74B$125.60M-0.841,360NHCNational HealthCareN/A$107.01-1.0%N/A-13.9%$1.65B$1.37B13.4112,400News CoveragePositive NewsTDOCTeladoc Health2.654 of 5 stars$8.73+3.8%$9.60+9.9%-11.1%$1.48B$2.57B-1.475,500Analyst ForecastGap DownAHCOAdaptHealth3.3025 of 5 stars$9.43-1.3%$13.40+42.1%-11.9%$1.29B$3.26B16.5410,500VRDNViridian Therapeutics3.2009 of 5 stars$13.98-2.4%$37.56+168.6%+31.6%$1.17B$300K-3.6350News CoveragePositive NewsCDNACareDx4.345 of 5 stars$19.54+1.6%$30.33+55.2%+27.6%$1.07B$333.79M16.99740Positive NewsInsider TradePNTGThe Pennant Group3.3928 of 5 stars$29.85+0.2%$34.60+15.9%-2.1%$1.03B$695.24M39.287,000High Trading VolumeAVAHAveanna Healthcare2.1547 of 5 stars$5.23+4.2%$5.13-2.0%+39.5%$979.37M$2.02B261.5033,500High Trading VolumeAGLAgilon Health2.3142 of 5 stars$2.31flat$4.79+107.2%-63.7%$956.23M$6.06B-3.921,076Analyst ForecastLFMDLifeMD1.5603 of 5 stars$13.62-0.9%$12.00-11.9%+79.9%$624.91M$212.45M-40.06230Positive NewsAnalyst Forecast Related Companies and Tools Related Companies GRAIL Competitors National HealthCare Competitors Teladoc Health Competitors AdaptHealth Competitors Viridian Therapeutics Competitors CareDx Competitors The Pennant Group Competitors Aveanna Healthcare Competitors Agilon Health Competitors LifeMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TALK) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored"I'm risking my reputation on this"Most people think you need thousands to profit from crypto. But this free book exposes how even small inves...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talkspace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
